Register now!Newsletter subscription

  • CATALOG PDF Download
  • BROCHURES PDF Download

useful for research for diabetes, complications of diabetes

Anti AGE-1 Monoclonal Antibody


The products of the nonenzymatic glycation and oxidation of proteins, lipids and nucleic acids, the advanced glycation end-products (AGEs), accumulate in various pathological conditions, such as diabetes, inflammation, renal failure, and aging. AGEs accumulate at site of microvascular injury in diabetes, including the kidney, the retina, and within the vasculature. The enhanced formation of AGEs also exists in various disease, such as atherosclerosis, Alzheimer’s disease, end-stage renal disease (ESRD), rheumatoid arthritis and liver cirrhosis.
AGEs can arise not only from glucose, but also from dicarbonyl compounds, short chain-reducing sugars and other metabolic pathways of glucose. It has been showed that glucose-derived AGEs (named AGE-1) causes apoptotic cell death and induces hyperfiltration and microalbuminuria by stimulating secretion of VEGF and MCP-1 proteins in the human mesangial cells. Therefore, AGE-1 may be involved in the pathogenesis of the early stage of diabetic nephropathy.
This antibody is specific to AGE-1 and will be useful to research for diabetes, complications of diabetes.

 AGEs Antibody Flyer [PDF]
 AGEs Antibody Flyer (print file) [PDF]


WB 0.1 µg/mL
IHC Not tested
ICC Not tested
ELISA 0.1 µg/mL
FCM Not tested
Neutralization Not tested
IP Not tested

Takeuchi M, et al., Mol Med. 1999 Jun;5(6):393-405. PMID: 10415164
Takeuchi M, et al., Mol Med. 2000 Feb;6(2):114-25. PMID: 10859028
Takeuchi M, et al., Mol Med. 2001 Nov;7(11):783-91. PMID: 11788793
Yamagishi S, et al., J Biol Chem. 2002 Jun 7;277(23):20309-15. Epub 2002 Mar 23. PMID: 11912219

This product is generated from GANP mice

Product List

Product Name Cat# Quantity Price

Anti AGE1

KAL-KG132 10UG

¥ 57,750
$ 770
€ 578

To be used for research only. DO NOT use for human gene therapy or clinical diagnosis.